Works from 2022
Advocating for equitable management of hereditary cancer syndromes, Rikki Gaber Caffrey (Article)
A radiation oncologist's experience with medical aid in dying, Santosh V. Yajnik (Article)
A randomized study of genetic education versus usual care in tumor profiling for advanced cancer in the ECOG-ACRIN Cancer Research Group (EAQ152), Angela R. Bradbury, Ju-Whei Lee, Jill Bennett Gaieski, et al. (Article)
Assessment of regional variability in COVID-19 outcomes among patients with cancer in the United States, Jessica E. Hawley, Mitrianna Streckfuss, Michael A. Thompson, et al. (Article)
BRE12-158: A postneoadjuvant, randomized phase II trial of personalized therapy versus treatment of physician's choice for patients with residual triple-negative breast cancer, Bryan P. Schneider, Guanglong Jiang, Tarah J. Ballinger, et al. (Article)
Defining comprehensive biomarker-related testing and treatment practices for advanced non-small-cell lung cancer: Results of a survey of U.S. oncologists, Kathryn F. Mileham, Caroline Schenkel, Suanna S. Bruinooge, et al. (Article)
Determining the stage of endometrial cancer for its surgical treatment, Elliot M. Levine and Carlos M. Fernandez (Letter)
Development and validation of a non-invasive, chairside oral cavity cancer risk assessment prototype using machine learning approach, Neel Shimpi, Ingrid Glurich, Reihaneh Rostami, et al. (Article)
Factors associated with breast cancer surgery delay within a coordinated multihospital community health system: When does surgical delay impact outcome?, Judy A. Tjoe, Kayla Heslin, Ana Cristina Perez, et al. (Article)
Geriatric risk factors for serious COVID-19 outcomes among older adults with cancer: A cohort study from the COVID-19 and Cancer Consortium, Arielle Elkrief, Cassandra Hennessy, Nicole M. Kuderer, et al. (Article)
HealthTree Cure Hub: A patient-derived, patient-driven clinical cancer information platform used to overcome hurdles and accelerate research in multiple myeloma, Nathan W. Sweeney, Jennifer M. Ahlstrom, Faith E. Davies, et al. (Article)
Implementing real-world RECIST-based tumor response assessment in patients with metastatic non-small cell lung cancer, Monika A Izano, Nguyet Tran, Alan Fu, et al. (Article)
Long-term outcomes for ibrutinib-rituximab and chemoimmunotherapy in CLL: Updated results of the E1912 trial, Tait D. Shanafelt, Xin Victoria Wang, Curtis A. Hanson, et al. (Article)
Loss of Rnf43 accelerates Kras-mediated neoplasia and remodels the tumor immune microenvironment in pancreatic adenocarcinoma, Abdel Nasser Hosein, Gita Dangol, Takashi Okumura, et al. (Article)
Mesothelioma, Nagarjun Rao and Shuanzeng Wei (Article)
National survey on the effect of oncology drug shortages in clinical practice: A Hematology Oncology Pharmacy Association Survey, Ali McBride, Sarah Hudson-DiSalle, Jeff Pilz, et al. (Article)
Navigated African American breast cancer patients as incidental change agents in their family/friend networks, Yamilé Molina, Shaila M. Strayhorn, Nyahne Q. Bergeron, et al. (Article)
Online medical misinformation in cancer: Distinguishing fact from fiction, Eleonora Teplinsky, Sara Beltrán Ponce, Emily K. Drake, et al. (Article)
Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: A CCC19 registry analysis, Samuel M. Rubinstein, Divaya Bhutani, Ryan C. Lynch, et al. (Article)
Pilot study to reliably measure the tissue concentration of mitomycin c after hyperthermic intraperitoneal chemotherapy in patients with gastrointestinal malignancies, Isaac Kriley, Noah Rozich, Geoffrey Bellini, et al. (Abstract)
Primary desmoplastic small round cell tumor of the femur: Case report and review of a rare intraosseous malignancy, Aarti E. Sharma, John A. deVries, Caitlin Agrawal, et al. (Article)
Racial disparities in COVID-19 outcomes among black and white patients with cancer, Julie Fu, Sonya A. Reid, Michael Thompson, et al. (Article)
Social media and professional development for oncology professionals, Anusha Chidharla, Audun Utengen, Deanna J. Attai, et al. (Article)
Structural racism is a mediator of disparities in acute myeloid leukemia outcomes, Ivy Elizabeth Abraham, Garth H. Rauscher, Anand Ashwin Patel, et al. (Article)
Translational advances in pancreatic ductal adenocarcinoma therapy, Abdel Nasser Hosein, Stephanie K. Dougan, Andrew J. Aguirre, et al. (Article)
Use of adjuvant bisphosphonates and other bone-modifying agents in breast cancer: ASCO-OH (CCO) guideline update, Andrea Eisen, Mark R. Somerfield, Melissa K. Accordino, et al. (Article)
YAP1 activation by human papillomavirus E7 promotes basal cell identity in squamous epithelia, Joshua Hatterschide, Paola Castagnino, Hee Won Kim, et al. (Article)
Works from 2021
Abdominal pain as the presenting symptom of Burkitt Lymphoma, Daniel Mundt and Brian Buggy (Poster)
Abstract 2618: Staged analysis of standard of care tumor molecular testing among patients with metastatic colorectal cancer in the community health system setting, Michael A. Thompson, Anthony Ruggeri, Jennifer Godden, et al. (Abstract)
Abstract p159: molecular tumor board impact at two large health systems, Jennifer Godden, Michael A. Thompson, James Weese, et al. (Abstract)
Abstract PS7-01: Characteristics and outcomes of SARS-CoV-2 infection in patients with invasive breast cancer (BC) from the COVID-19 and cancer consortium (CCC19) cohort study, Ali Raza Khaki, Dimpy Shah, Michael A. Thompson, et al. (Abstract)
A call to action: unified clinical practice guidelines for oncofertility care, Jacqueline Sehring, Anisa Hussain, Lauren Grimm, et al. (Article)
A case report of blastic plasmacytoid dendritic cell neoplasm in a hispanic child, Katy Ordoñez Tanchiva, Pamela Contreras Chavez, Silvana Lucero Loli Guevara, et al. (Article)
Adjuvant therapy in patients with sarcomatoid renal cell carcinoma: Post hoc analysis from Eastern Cooperative Oncology Group-American College of Radiology Imaging Network (ECOG-ACRIN) E2805, Jose A Karam, Maneka Puligandla, Keith T Flaherty, et al. (Article)
An open-label, randomized, multi-center study comparing the sequence of high dose aldesleukin (interleukin-2) and ipilimumab (yervoy) in patients with metastatic melanoma, Merve Hasanov, Denái R. Milton, William H. Sharfman, et al. (Article)
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium, P Grivas, A R Khaki, T M Wise-Draper, et al. (Article)
Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19, Michael A. Thompson, Jeffrey P Henderson, Pankil K Shah, et al. (Article)
Association of smoking status and recurrence of non-muscle invasive bladder cancer among patients managed with blue light cystoscopy, Richard S Matulewicz, Kourosh Ravvaz, John A. Weissert, et al. (Article)
Atezolizumab-induced hemolytic anemia - A case report, Christina M. Younce, Jessica M. Lawton, and Dhimant Patel (Case Report)
AXL receptor is required for Zika virus strain MR-766 infection in human glioblastoma cell lines, Samuel D. Zwernik, Beau H. Adams, Daniel A. Raymond, et al. (Article)
Breast cancer recurrence risk after hormonal contraceptive use in survivors of reproductive age, Molly K. Ostroot, Kayla Heslin, Jessica J F Kram, et al. (Article)
Cancer control in Latin America and the Caribbean: Recent advances and opportunities to move forward, Carlos H. Barrios, Gustavo Werutsky, Alejandro Mohar, et al. (Article)
Cardiac MRI: A clinical decision-making tool for isolated right ventricle mass associated with hepatocellular carcinoma, Sujeen Adhikari, Katarzyna Mikrut, Erik Skulborstad, et al. (Oral/Podium Presentation)
Care without a compass: including patients with cancer in COVID-19 studies, Christopher R Friese, Toni K Choueiri, Narjust Duma, et al. (Article)
Clinical responses of oncolytic coxsackievirus A21 (V937) in patients with unresectable melanoma, Andtbacka, Brendan Curti, Gregory A Daniels, et al. (Article)
Clinicopathological criteria predictive of recurrence following bacillus Calmette-Guérin therapy Initiation in non-muscle-invasive bladder cancer: Retrospective cohort study, Joseph Plasek, John Weissert, Tracy Downs, et al. (Article)
Colorectal cancer in 18- to 49-year-olds: rising rates, presentation, and outcome in a large integrated health system, Nimish Vakil, Kristin Ciezki, and Maharaj Singh (Article)
COVID-19 and cancer: A review of the registry-based pandemic response, Aakash Desai, Turab J Mohammed, Narjust Duma, et al. (Article)
Demographics, Treatment and Survival for Patients Diagnosed With Pancreatic Cancer 2010-2016, Maharaj Singh and Michelle Simpson (Abstract)
De-novo acute myeloid leukemia in a BRCA positive female with locally treated ductal carcinoma in situ, Edward Nabrinsky, Faisal Masood, Sufyan Abdulmujeeb, et al. (Article)
Diagnosis of uncommon adamantinoma in older patients, Henok Hardilo, Chiamaka Ogemdi Isiguzo, and Biana Leybishkis (Poster)
Dosimetric benefits of omitting primary tumor beds in postoperative radiotherapy after transoral robotic surgery using the auto-planning technique, Taoran Cui, Matthew C. Ward, Jeffrey A. Kittel, et al. (Article)
Durable response to pembrolizumab in a patient with uterine serous carcinoma and Lynch Syndrome due to the MSH6 germline mutation, Kelsey T Danley, Karen Schmitz, Ritu Ghai, et al. (Article)
ECOG-ACRIN EAA181: Effective quadruplet utilization after treatment evaluation (EQUATE)—a randomized phase 3 trial for newly diagnosed multiple myeloma (NDMM) not intended for early autologous transplantation, Shaji Kumar, Zihan Wei, Michael A. Thompson, et al. (Abstract)
Evolution in the Presence and Evidence Category of Radiation Therapy Treatment Recommendations in National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology, Rachael Conger, Javier Mora, MW Straza Jr, et al. (Abstract)
Fatal GNAQ-mutated CNS melanoma in an adolescent with nevus of Ota, Andrew R Blundell, Danna Moustafa, Wesley R Samore, et al. (Article)
Feasibility of 18-MV grid therapy from radiation protection aspects: unwanted dose and fatal cancer risk caused by photoneutrons and scattered photons, Amir Hossein Karimi, Seyed Farshad Mirian, Farshid Mahmoudi, et al. (Article)
High-risk mantle cell lymphoma in the era of novel agents, Edward Nabrinsky, Alexey V Danilov, and Paul B Koller (Article)
Histologic discordance between primary tumor and nodal metastasis in breast cancer: Solving a clinical conundrum in the era of genomics, Nicole K Yun, Jessica A Slostad, Ankur Naqib, et al. (Article)
Hypofractionated radiation in secretory breast cancer: A case report, Ken Tatebe, Claudia Perez, Lydia Usha, et al. (Article)
Identification of potential germline (GL) variants by routine clinical comprehensive genomic profiling (CGP) and confirmatory GL testing in 24 tumor types, Kristen Hanson, Michael P. Mullane MD, Deborah Wham, et al. (Abstract)
Immune function in childhood cancer survivors: a Children's Oncology Group review, Gregory M T Guilcher, Linda Rivard, Jennifer T Huang, et al. (Article)
Impact of the COVID-19 pandemic on oncologist burnout, emotional well-being, and moral distress: Considerations for the cancer organization's response for readiness, mitigation, and resilience, Fay J Hlubocky, Banu E Symington, Daniel C McFarland, et al. (Article)
Ixazomib-lenalidomide-dexamethasone in routine clinical practice: effectiveness in relapsed/refractory multiple myeloma, Roman Hájek, Jiří Minařík, Jan Straub, et al. (Article)
Measurable residual disease does not preclude prolonged progression-free survival in CLL treated with ibrutinib, Victoria Wang, Curtis A Hanson, Renee Tschumper, et al. (Article)
Modernizing clinical trial eligibility criteria: Recommendations of the ASCO-Friends of Cancer Research Laboratory Reference Ranges and Testing Intervals Work Group, Alexander I Spira, Mark D Stewart, Suzanne Jones, et al. (Article)
Modernizing clinical trial eligibility criteria: Recommendations of the ASCO-Friends of Cancer Research Prior Therapies Work Group, Raymond U Osarogiagbon, Diana Merino Vega, Lola Fashoyin-Aje, et al. (Article)
Molecular biomarker testing and targeted therapy patterns in patients with acute myelogenous leukemia (aml) in community health systems in the united states: a real-world data analysis, Zartash Gul and Michael A. Thompson (Abstract)
MPN-390: Study design and objectives for a new cohort of patients with myelofibrosis (MF) enrolled in the ongoing Connect® Myeloid Disease Registry, John Mascarenhas, Michael Savona, Michael A. Thompson, et al. (Abstract)
Myasthenia gravis induced or exacerbated by immune checkpoint inhibitors: a rising concern, Behnam Hajihossainlou, Alisa Vasileva, Sukesh Manthri, et al. (Article)
Nasal embryonal rhabdomyosarcoma in the pediatric population: literature review and report of midline presentation, Jordan H Larson, Rachel Rutledge, Laura Hunnell, et al. (Article)
National Cancer Database Analysis of Outcomes in Patients Diagnosed With Glioblastoma, Maharaj Singh, Parvez Akhtar, and Richard Rovin (Abstract)
Oncofetal chondroitin sulfate is a highly expressed therapeutic target in non-small cell lung cancer, Htoo Zarni Oo, Zoltan Lohinai, Nastaran Khazamipour, et al. (Article)
Oncogenic KRAS requires complete loss of BAP1 function for development of murine intrahepatic cholangiocarcinoma, Rebecca Marcus, Sammy Ferri-Borgogno, Abdel Hosein, et al. (Article)
P10.03 Pembrolizumab with or without chemotherapy for advanced lung cancer: A real-world analysis of key prognostic factors, S Gadgeel, Mohamed Hendawi, James Weese, et al. (Abstract)
Paragangliomas of the Larynx: An Evidence Based Review, Jaspreet Amar and Inna Husain (Poster)
Pembrolizumab plus ipilimumab following anti-PD-1/L1 failure in melanoma, Olson, Zeynep Eroglu, Bruce Brockstein, et al. (Article)
Pemigatinib-induced nail changes - A case report, Nicolle A. Trudeau, Jessica M. Lawton, and Nirav D. Patel (Case Report)
People with cancer are likely to accept the covid-19 vaccine, but politics tracks with attitudes: An inspire and cosmo survey, Don Dizon, Kathleen Hoffman, Michael A. Thompson, et al. (Abstract)
Perforating Duodenal Ulcer with Umbilical Herniation as a Metastatic Complication of Primary Signet Ring Cell Carcinoma of the Breast, Daniel R Principe, Andreea Raicu, Jose Cataneo, et al. (Article)
Phase I trial of intravesical Bacillus Calmette-Guérin combined with intravenous pembrolizumab in recurrent or persistent high-grade non-muscle-invasive bladder cancer after previous Bacillus Calmette-Guérin treatment, Shaheen Alanee, Sherjeel Sana, Ahmed El-Zawahry, et al. (Article)
Predicting disease recurrence, early progression, and overall survival following surgical resection for high-risk localized and locally advanced renal cell carcinoma, Andres F Correa, Opeyemi A Jegede, Naomi B Haas, et al. (Article)
Predictive and prognostic effects of primary tumor size on colorectal cancer survival, Olatunji B. Alese, Wei Zhou, Renjian Jiang, et al. (Article)
Primary central nervous system lymphoma with systemic recurrence, Sasirekha Pandravada, Phillip Knouse, and Jacob Bitran (Article)
Prognostic Implications of Vitamin D in Patients With a Hematologic Malignancy at a Large Health System in Wisconsin, Daniel Mundt, Marianne Klumph, Kayla Heslin, and Michael A. Thompson (Abstract)
Pulmonary open, robotic and thoracoscopic lobectomy (PORTaL) study: An analysis of 5,721 cases, Michael S Kent, Matthew G Hartwig, Eric Vallières, et al. (Article)
Race and gender differences in awareness of colorectal cancer screening tests and guidelines among recently diagnosed colon cancer patients in an urban setting, Leslie R Carnahan, Lindsey Jones, Katherine C Brewer, et al. (Article)
Radium Ra 223 apha therapy for prostate cancer bone metastasis, Timothy Strane (Article)
Rapid real-world data analysis of patients with cancer, with and without COVID-19, across distinct health systems, Clara Hwang, Monika A Izano, Michael A. Thompson, et al. (Article)
Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the US, Faith Davies, Robert Rifkin, Caitlin Costello, et al. (Article)
Real-world diagnostic testing patterns for assessment of ring sideroblasts and SF3B1 mutations in patients with newly diagnosed lower-risk myelodysplastic syndromes, Jay L Patel, Mehrdad Abedi, Christopher R Cogle, et al. (Article)
Real-world performance of a comprehensive genomic profiling test optimized for small tumor samples, Scott A. Tomlins, Daniel H. Hovelson, Jennifer M. Suga, et al. (Article)
Recommendations to streamline and standardize clinical trial site feasibility assessments: An ASCO research statement, Dax Kurbegov, Patricia Hurley, David M Waterhouse, et al. (Article)
Re-evaluating tumors of purported specialized prostatic stromal origin reveals molecular heterogeneity, including non-recurring gene fusions characteristic of uterine and soft tissue sarcoma subtypes, Andres M Acosta, Lynette M Sholl, Brendan C Dickson, et al. (Article)
Refining a Postpandemic Approach to Cancer Screening, Michael A. Thompson (From the Editor)
Salubrinal exposes anticancer properties in inflammatory breast cancer cells by manipulating the endoplasmic reticulum stress pathway, Andrew Alsterda, Kumari Asha, Olivia Powrozek, et al. (Article)
The American Society of Pain and Neuroscience (ASPN) best practices and guidelines for the interventional management of cancer-associated pain, Mansoor M. Aman, Ammar Mahmoud, Timothy Deer, et al. (Article)
The CoVID-TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID-19, Ang Li, Nicole M Kuderer, Chih-Yuan Hsu, et al. (Article)
The role of navitoclax in myelofibrosis, Sasirekha Pandravada and Steven Sandler (Article)
Treatment patterns and survival outcomes of patients with acute myeloid leukemia who achieved remission in the connect ® myeloid disease registry, Michael A. Thompson (Abstract)